Skip to main content
Erschienen in: Breast Cancer 2/2018

16.09.2017 | Original Article

Margin-free excision of small solid breast carcinomas using the Intact Breast Lesion Excision System®: is it feasible?

verfasst von: Ioannis K. Papapanagiotou, Dimitra Koulocheri, Vasileios Kalles, Paraskevi Liakou, Nikolaos V. Michalopoulos, Wasim Al-Harethee, Georgia Georgiou, Maria Matiatou, Afroditi Nonni, Anastasia Pazaiti, Georgios E. Theodoropoulos, Evangelos Menenakos, Georgios C. Zografos

Erschienen in: Breast Cancer | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The Breast Lesion Excision System® (BLES®) is a stereotactic vacuum-assisted breast biopsy device that utilizes radiofrequency in order to excise non-palpable mammographic lesions for pathologic diagnosis. The purpose of this study was to evaluate the efficacy of BLES® in performing complete, margin-free excisions of small solid carcinomas.

Methods

Our retrospective study of prospectively enrolled patients included 50 cases of non-palpable, BIRADS ≥ 4, solid by means of mammography and sonography, lesions. All these patients underwent a BLES® breast biopsy procedure from June 2010 to June 2014 and had a malignant diagnosis. According to each patient’s pathologic diagnosis, appropriate surgical treatment was recommended. Postoperatively, surgical specimens were histologically analyzed, aiming to determine whether residual malignant disease was present in the specimen cavity formatted by BLES®.

Results

Ductal carcinoma in situ (DCIS) was diagnosed in 5 patients and invasive carcinoma (IC) in 45 patients, at primary BLES® pathology report. Tumor-free resection margins (< 0.5 and < 1 mm) were accomplished in only 8/24 subcentimeter cases (33.3%). Absence of residual disease upon surgical excision was confirmed in 23/24 subcentimeter cases (95.8%) and 2/26 of the cases measuring > 1 cm (7.69%). Statistical analysis revealed that mammographic size was the only significant prognostic factor for complete excision (i.e., with no residual disease in the biopsy cavity) of a malignant lesion.

Conclusions

Our results indicate that it is possible, when using the BLES® device, to completely excise small (≤ 10 mm) breast carcinomas that appear radiologically as solid lesions. This subset of patients should be investigated regarding the therapeutic potential of this method.
Literatur
1.
Zurück zum Zitat Liberman L. Centennial dissertation. Percutaneous imaging-guided core breast biopsy: state of the art of the millennium. AJR Am J Roentgenol. 2000;174(5):1191–9.CrossRefPubMed Liberman L. Centennial dissertation. Percutaneous imaging-guided core breast biopsy: state of the art of the millennium. AJR Am J Roentgenol. 2000;174(5):1191–9.CrossRefPubMed
2.
Zurück zum Zitat Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist. 2006;11(5):435–49.CrossRefPubMed Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist. 2006;11(5):435–49.CrossRefPubMed
3.
Zurück zum Zitat Zografos GC, Zagouri F, Sergentanis TN, et al. Minimizing underestimation rate of microcalcifications excised via vacuum-assisted breast biopsy: a blind study. Breast Cancer Res Treat. 2008;109(2):397–402.CrossRefPubMed Zografos GC, Zagouri F, Sergentanis TN, et al. Minimizing underestimation rate of microcalcifications excised via vacuum-assisted breast biopsy: a blind study. Breast Cancer Res Treat. 2008;109(2):397–402.CrossRefPubMed
4.
Zurück zum Zitat Sie A, Bryan DC, Gaines V, et al. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device. Cancer. 2006;107(5):945–9. doi:10.1002/cncr.22090.CrossRefPubMed Sie A, Bryan DC, Gaines V, et al. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device. Cancer. 2006;107(5):945–9. doi:10.​1002/​cncr.​22090.CrossRefPubMed
5.
Zurück zum Zitat Killebrew LK, Oneson RH. Comparison of the diagnostic accuracy of a vacuum-assisted percutaneous intact specimen sampling device to a vacuum-assisted core needle sampling device for breast biopsy: initial experience. Breast J. 2006;12(4):302–8.CrossRefPubMed Killebrew LK, Oneson RH. Comparison of the diagnostic accuracy of a vacuum-assisted percutaneous intact specimen sampling device to a vacuum-assisted core needle sampling device for breast biopsy: initial experience. Breast J. 2006;12(4):302–8.CrossRefPubMed
8.
Zurück zum Zitat Lomoschitz FM, Helbich TH, Rudas M, et al. Stereotactic 11-gauge vacuum-assisted breast biopsy: influence of number of specimens on diagnostic accuracy. Radiology. 2004;232(3):897–903.CrossRefPubMed Lomoschitz FM, Helbich TH, Rudas M, et al. Stereotactic 11-gauge vacuum-assisted breast biopsy: influence of number of specimens on diagnostic accuracy. Radiology. 2004;232(3):897–903.CrossRefPubMed
9.
Zurück zum Zitat Whitworth PW, Simpson J, Poller WR, et al. Definitive diagnosis for high-risk breast lesions without open surgical excision: the intact percutaneous excision trial (IPET). Ann Surg Oncol. 2011;18:3047–52. doi:10.1245/s10434-011-1911-0.CrossRefPubMed Whitworth PW, Simpson J, Poller WR, et al. Definitive diagnosis for high-risk breast lesions without open surgical excision: the intact percutaneous excision trial (IPET). Ann Surg Oncol. 2011;18:3047–52. doi:10.​1245/​s10434-011-1911-0.CrossRefPubMed
10.
Zurück zum Zitat Allen SD, Nerurkar A, Della Rovere GU. The Breast Lesion Excision System (BLES): a novel technique in the diagnostic and therapeutic management of small indeterminate breast lesion? Eur Radiol. 2011;21(5):919–24. doi:10.1007/s00330-010-2000-7.CrossRefPubMed Allen SD, Nerurkar A, Della Rovere GU. The Breast Lesion Excision System (BLES): a novel technique in the diagnostic and therapeutic management of small indeterminate breast lesion? Eur Radiol. 2011;21(5):919–24. doi:10.​1007/​s00330-010-2000-7.CrossRefPubMed
11.
Zurück zum Zitat Allen SD, Osin P, Nerurkar A. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years. Eur J Surg Oncol. 2014;40(7):824–9. doi:10.1016/j.ejso.2014.03.022.CrossRefPubMed Allen SD, Osin P, Nerurkar A. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years. Eur J Surg Oncol. 2014;40(7):824–9. doi:10.​1016/​j.​ejso.​2014.​03.​022.CrossRefPubMed
13.
Zurück zum Zitat Seror JY, Lesieur B, Scheuer-Niro B, et al. Predictive factors for complete excision and underestimation of one-pass en bloc excision of non-palpable breast lesions with the Intact® breast lesion excision system. Eur J Radiol. 2012;81(4):719–24. doi:10.1016/j.ejrad.2011.01.049.CrossRefPubMed Seror JY, Lesieur B, Scheuer-Niro B, et al. Predictive factors for complete excision and underestimation of one-pass en bloc excision of non-palpable breast lesions with the Intact® breast lesion excision system. Eur J Radiol. 2012;81(4):719–24. doi:10.​1016/​j.​ejrad.​2011.​01.​049.CrossRefPubMed
14.
Zurück zum Zitat Medjhoul A, Canale S, Mathieu MC, et al. Breast lesion excision sample (BLES biopsy) combining stereotactic biopsy and radiofrequency; is it a safe and accurate procedure in case of BIRADS 4 and 5 breast lesions? Breast J. 2013;19(6):590–4. doi:10.1111/tbj.12184.CrossRefPubMed Medjhoul A, Canale S, Mathieu MC, et al. Breast lesion excision sample (BLES biopsy) combining stereotactic biopsy and radiofrequency; is it a safe and accurate procedure in case of BIRADS 4 and 5 breast lesions? Breast J. 2013;19(6):590–4. doi:10.​1111/​tbj.​12184.CrossRefPubMed
15.
Zurück zum Zitat Reston VA. BIRADS atlas. 4th ed. USA: American College of Radiology; 2003. Reston VA. BIRADS atlas. 4th ed. USA: American College of Radiology; 2003.
17.
Zurück zum Zitat College of American Pathologists. Protocol for the examination of specimens from patients with DCIS of the breast. 2009. http://www.cap.org. Accessed 16 Sept 2017. College of American Pathologists. Protocol for the examination of specimens from patients with DCIS of the breast. 2009. http://​www.​cap.​org. Accessed 16 Sept 2017.
18.
Zurück zum Zitat College of American Pathologists. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. 2009. http://www.cap.org. Accessed 16 Sept 2017. College of American Pathologists. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. 2009. http://​www.​cap.​org. Accessed 16 Sept 2017.
19.
Zurück zum Zitat Ellis IO, Carder P, Hales S, et al. Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer. Update on NHSBSP Guidelines for Pathology Reporting in Breast Cancer Screening and The Royal College of Pathologists Standards and datasets for reporting cancers: Dataset for histological reporting of breast cancer. The Royal College of Pathologists, June 2016. http://www.rcpath.org. Ellis IO, Carder P, Hales S, et al. Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer. Update on NHSBSP Guidelines for Pathology Reporting in Breast Cancer Screening and The Royal College of Pathologists Standards and datasets for reporting cancers: Dataset for histological reporting of breast cancer. The Royal College of Pathologists, June 2016. http://​www.​rcpath.​org.
20.
Zurück zum Zitat Evans A, Pinder S, Wilson R, et al. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. AJR Am J Roentgenol. 1994;162(6):1307–11.CrossRefPubMed Evans A, Pinder S, Wilson R, et al. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. AJR Am J Roentgenol. 1994;162(6):1307–11.CrossRefPubMed
21.
Zurück zum Zitat Casey M, Rosenblatt R, Zimmerman J, Fineberg S. Mastectomy without malignancy after carcinoma diagnosed by large-core stereotactic breast biopsy. Mod Pathol. 1997;10(12):1209–13.PubMed Casey M, Rosenblatt R, Zimmerman J, Fineberg S. Mastectomy without malignancy after carcinoma diagnosed by large-core stereotactic breast biopsy. Mod Pathol. 1997;10(12):1209–13.PubMed
22.
Zurück zum Zitat Wiley EL, Diaz LK, Badve S, Morrow M. Effect of time interval on residual disease in breast cancer. Am J Surg Pathol. 2003;27:194–8.CrossRefPubMed Wiley EL, Diaz LK, Badve S, Morrow M. Effect of time interval on residual disease in breast cancer. Am J Surg Pathol. 2003;27:194–8.CrossRefPubMed
23.
Zurück zum Zitat Scopa C, Aroukatos P, Tsamandas A, Aletra C. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma. Breast J. 2006;12(2):150–3.CrossRefPubMed Scopa C, Aroukatos P, Tsamandas A, Aletra C. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma. Breast J. 2006;12(2):150–3.CrossRefPubMed
24.
Zurück zum Zitat Nasir N, Rainsbury RM. The timing of surgery affects the detection of residual disease after wide local excision of breast carcinoma. Eur J Surg Oncol. 2003;29:718–20.CrossRefPubMed Nasir N, Rainsbury RM. The timing of surgery affects the detection of residual disease after wide local excision of breast carcinoma. Eur J Surg Oncol. 2003;29:718–20.CrossRefPubMed
25.
26.
Zurück zum Zitat National Breast and Ovarian Cancer Center and Australian Cancer Network: The Pathology Reporting of Breast Cancer, 3rd edn. 2008. http://www.nbocc.org. Accessed 16 Sept 2017. National Breast and Ovarian Cancer Center and Australian Cancer Network: The Pathology Reporting of Breast Cancer, 3rd edn. 2008. http://​www.​nbocc.​org. Accessed 16 Sept 2017.
Metadaten
Titel
Margin-free excision of small solid breast carcinomas using the Intact Breast Lesion Excision System®: is it feasible?
verfasst von
Ioannis K. Papapanagiotou
Dimitra Koulocheri
Vasileios Kalles
Paraskevi Liakou
Nikolaos V. Michalopoulos
Wasim Al-Harethee
Georgia Georgiou
Maria Matiatou
Afroditi Nonni
Anastasia Pazaiti
Georgios E. Theodoropoulos
Evangelos Menenakos
Georgios C. Zografos
Publikationsdatum
16.09.2017
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 2/2018
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-017-0802-z

Weitere Artikel der Ausgabe 2/2018

Breast Cancer 2/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.